期刊文献+

金黄杆菌属β内酰胺酶基因型研究 被引量:2

Investigation of β-lactamase genotypes of Chryseobacterium/Flavobacterium spp.
原文传递
导出
摘要 目的了解金黄杆菌属β内酰胺酶基因型的分布。方法采用琼脂稀释法检测43株脑膜炎败血金黄杆菌、16株产吲哚金黄杆菌和10株黏金黄杆菌对15种抗生素的最低抑菌浓度;用三维试验和改良三维试验检测碳青霉烯酶;用2-巯基丙酸协同试验检测金属酶;用6对针对金黄杆菌属的特异性引物扩增金黄杆菌的β内酰胺酶基因并测序。结果喹诺酮类抗生素的 MIC_(50)和 MIC_(90)较低,其余的抗生素的 MIC 值均很高,黏金黄杆菌的 MIC 值要低于其他两种金黄杆菌。表型筛选试验脑膜炎败血金黄杆菌中共检测到26株产金属酶,阳性率为60.5%,43株全部产超广谱β内酰胺酶,阳性率为100%;产吲哚金黄杆菌和黏金黄杆菌均未检出超广谱β内酰胺酶,产吲哚金黄杆菌检出11株金属酶,阳性率为68.8%;黏金黄杆菌检出6株金属酶,阳性率为60%。脑膜炎败血金黄杆菌检出金属酶基因型 Bla-B1、B2、B3、B5、B11共5种,Bla-GOB2、GOB4、GOB6、GOB8共4种;检出超广谱β内酰胺酶 CME-1型1种。产吲哚金黄杆菌3株均为 IND-1型金属酶基因型。黏金黄杆菌检出6株 CGB 金属酶基因型。同时发现产吲哚金黄杆菌有8株,黏金黄杆菌有3株没有检测到目前国内外所报道的基因型。结论金黄杆菌属基因型的研究为临床抗生素的合理应用,降低医院感染以及新型抗生素的开发提供重要的指导意义。 Objective To understand the distribution of the genotypes of β-lactamases in Chryseobacterium/Flavobacterium spp. Methods Minimum inhibitory concentrations (MICs) of 43 Chryseobaclerium meningosepticum strains, 22 Chryseobacterium indologenes strains and 10 Chryseobacterium gleum strains against 15 antibiotics were determined by agar dilution method. 3-D test and modified 3-D test were used to identify carbapenamase. 2-mercaptopropionic acid inhibitory test was used to confirm metallo-β-lactamases (MBL). Genes of β-1actamases were amplified with 6 pairs of primers special for Chryseobacterium/Flavobacterium spp. and the amplified genes were sequenced. Results MIC50 and MIC50 of quinolones were lower comparing to other antibiotics. MICs of C. gleum against 15 antibiotics were lower than other Chryseobacterium/Flavobacterium spp. Among 43 C. meningosepticum strains, 26 strains (60. 5% ) produce MBL, but all strains (100%) produced extended-spectrum β-lactamases (ESBLs) ; 12 C. indolagenes strains (68. 8% ) produced MBL; 6 (60%) C. gleum strains had MBL Genotypes of MBL in C. meningesepticum strains were Bla-B 1,2,3,5 and 11, and Bla-GOB 2,4,6 and 8, respectively. Only one genotype, namely CME-1, was identified for ESBL in C. meningosepticum. The genotype of MBL in 3 C. indolgenes strains was IND-1, and the 6 C. gleum strains contained CGB genotype. Meanwhile, there were 8 C. indolgenes strains and 3 C. gleum strains were confirmed to produce β-lactamase, but their genotypes were unable to be detected using the current primers, implying that there were possible novel genotypes. Conclusions Investigation of genotypes distribution of β-lactamase in Chryseobacterium/ Flavobacterium spp. can provide theoretical evidences and rational in the selection of antibiotics, control of noscomical infection and development of novel antibiotics.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2007年第3期319-322,共4页 Chinese Journal of Laboratory Medicine
关键词 金黄杆菌属 Β内酰胺酶类 基因 研究 Chryseobacterium β-1actamases Genes
  • 相关文献

参考文献8

  • 1Lim LC, Low JA, Chan KM. Chryseobacterium meningosepticum ( Flavobaetefium meningosepticum) a report of five cases in a local hospital. Ann Acad Med Singapore, 1999,28:858-860.
  • 2Bossolini GM, Franceschini N, Riccio ML,et al. Characterization and sequence of the chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B betalactamase showing a broad substrate profile. Biochem J, 1998,332 : 145-152.
  • 3Vessillier S, Docquier JD, Rival S, et al. Overproduction and biochemical characterization of the Chryseobacterium menlngosepticum BlaB metallo-beta-lactamase. Antimicrob Agents Chemother,2002,46:1921-1927.
  • 4Bellais S, Poirel L, Leotard S, et al. Genetic diveraity of carbapenem-hydrolyzing metallo-beta-lactamases from Chryseobacterium ( Flavobacterium ) indologenes. Antimicrob Agents Chemother,2000 ,44 :3028-3034.
  • 5Bellais S, Naas T, Nordmann P. Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing beta-lactamase from Chryseobacterium gleum.Antimicrob Agents Chemother,2002 ,46 :2791-2796.
  • 6National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard M7-A7 (M100-S16).Wayne, Pa. 2006.
  • 7Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol,2000,38:40-43.
  • 8张嵘,朱百荣,周田美,董小勤,杨青,孔海深,吕火祥.杭州市脑膜炎败血黄杆菌的分离和药敏谱分析[J].中华检验医学杂志,2003,26(8):481-483. 被引量:18

二级参考文献10

  • 1Liu CE, Wong WW, Yang SP, et al. Flavobacterium meningosepticum bacteriemia: an analysis of 16 cases. Zhanghua YiXue Za Zhi-(Taipei) ,1999,62: 125-132.
  • 2Merino LA, Ronconi MC, Marin M, et al. Non-fermenting Gramnegative bacilli: distribution in clinical specimens and antimicrobial susceptibility. Rev Latinoam Microbiol, 1999, 41:279-284.
  • 3Tizer KB, Cervia JS, Dunn AM, et al. Succesdul combination vancomycin and rifampin therapy in a newborn with communityacquired Flavobacterium meningosepticum neonatal meningitis.Pediatr Infect Dis J, 1995,14:916-917.
  • 4Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother, 1997, 41:2738-2741.
  • 5Lira LC, Low JA, Chart KM. Chryseobacterium meningosepticum (Flavobacterium meniagosepticum) - a report of five cases in a local hospital. Ann Acad Med Singapore, 1999,28: 857-860.
  • 6Nulens E, Bussels B, Bols A, et al. Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect, 2001,7:391-393.
  • 7National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4^th ed. Approved Standard M7-A4. Pennsylvania:NCCLS, 1997.76-77.
  • 8Pokrywka M, Viazanko K, Medvick J, et al. A Fiavobacterium meningosepticum outbreak among intensive care patients. Am J Infect Control, 1993,21:139-145.
  • 9Hoque SN, Graham J, Kaufmann ME, et al. Chryseobacterium( Flavobacterium ) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect, 2001,47:188-192.
  • 10Kare.,C. Roha.,N.脑膜炎败血黄杆菌:免疫受损病人的潜在致病菌:6例报告及文献回顾[J].世界医学杂志,1998,2(1):9-17. 被引量:2

共引文献17

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部